{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-008192","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.357276+00:00","generated_at":"2026-06-26T09:52:19.309153+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"The Oncology Institute names Mihir Shah as CFO; Dalgleish departs","bullets":["Scott Dalgleish ceases as CFO effective April 4, 2022; receives 3-month salary continuation and $47,750 bonus.","Mihir Shah appointed CFO, effective April 4, 2022; previously CFO at Commonwealth Care Alliance ($2B revenue).","Shah's annual base salary $405,000, target bonus 40%, and equity award of $453,085 (67% options, 33% RSUs).","Diona Simoneit, Chief Accounting Officer, appointed principal accounting officer effective April 1, 2022.","Press release issued April 4, 2022; departure unrelated to financial condition or controls."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-008192","json":"https://secwatch.observer/filing/0001628280-22-008192.json","markdown":"https://secwatch.observer/filing/0001628280-22-008192.md","text":"https://secwatch.observer/filing/0001628280-22-008192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022008192/0001628280-22-008192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022008192/toi-20220401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:52:19.309153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83bfddc095","claim":"Mihir Shah was appointed as Chief Financial Officer at Oncology Institute, Inc..","evidence_excerpt":"Effective as of April 4, 2022, the Company appointed Mihir Shah, to replace Mr. Dalgleish as the Company’s Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022008192/0001628280-22-008192-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"9cd61b3545","claim":"Scott Dalgleish departed as Chief Financial Officer at Oncology Institute, Inc..","evidence_excerpt":"Mr. Dalgleish will cease serving as the Company’s Chief Financial Officer effective April 4, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022008192/0001628280-22-008192-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving as"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}